
Loading, please wait...

Loading, please wait...

The diagnosis of neonatal Kommerell diverticulum on the first day of life is exceptionally rare. In this recent case report, clinicians identified a right aortic arch accompanied by a retroesophageal diverticulum. Significantly, the patient also presented with an unusual mid-ductal aneurysmal dilatation of the patent ductus arteriosus (PDA). This specific combination provides a unique opportunity to study the early natural history of complex vascular anomalies.
Serial echocardiography played a crucial role in monitoring the infant. These examinations documented the spontaneous closure of the ductus and subsequent thrombosis formation. Moreover, CT imaging confirmed the presence of a right aortic arch and the specific anatomy of the retroesophageal neonatal Kommerell diverticulum. Although the infant remains asymptomatic, close surveillance is mandatory. This monitoring helps detect any potential compression of the trachea or esophagus as the child grows.
Managing asymptomatic neonatal patients with such complex vascular anatomy remains a significant challenge. Currently, clinicians often prefer a conservative approach with regular imaging. However, if the diverticulum causes respiratory distress or feeding difficulties, surgical intervention becomes necessary. This case highlights how serial imaging can guide the timing of potential interventions. Additionally, it allows for the observation of the natural evolution of ductal aneurysms in the neonatal period.
A Kommerell diverticulum is a rare aortic arch anomaly that can lead to the formation of a vascular ring. In neonates, it may cause compression of the trachea or esophagus. Nevertheless, some cases remain asymptomatic and require only close monitoring through serial imaging.
Clinicians usually diagnose this condition using echocardiography and confirm the anatomy with CT or MRI. Early detection allows for serial imaging to monitor the natural history of associated anomalies, such as a patent ductus arteriosus or aneurysmal dilatations.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
1. Lim YT et al. Neonatal Kommerell diverticulum with mid-ductal aneurysmal patent ductus arteriosus: serial imaging documentation of early natural history. Cardiol Young. 2026 Feb 13. doi: 10.1017/S1047951126111470. PMID: 41680967.
2. Al-Mashaqbeh M et al. Management of pediatric Kommerell's diverticulum and vascular rings. PMC. 2025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11617255/
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A case study of neonatal Kommerell diverticulum and aneurysmal PDA, highlighting the importance of serial imaging in managing asymptomatic newborns....
8 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today